← Back
$TMDX All transactions

TransMedics Group, Inc.

▼ SELL 10b5-1 Plan

$ Value

$540K

Shares

4,142

Price

$130

Filed

Oct 31

Insider

Name

Basile Edward M

Title

CIK

0001773661

Roles

Director

Transaction Details

Transaction Date

2025-10-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,866

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 6, 2024. | The option is fully vested. | The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

Filing Info

Accession No.

0001193125-25-260849

Form Type

4

Issuer CIK

0001756262

Basile Edward M's History

Date Ticker Type Value
2025-10-29 TMDX M $3K
2025-10-29 TMDX $540K
2025-10-29 TMDX M
2025-08-04 TMDX M $3K
2025-08-04 TMDX $520K
2025-08-04 TMDX M
2025-05-27 TMDX M $4K
2025-05-27 TMDX $632K
2025-05-27 TMDX M
2025-05-22 TMDX A $0

Other Insiders at TMDX (90d)

Insider Bought Sold Last
Lovell Stephanie $178K 2026-03-04
Weill David $524K 2026-03-04
Corcoran Nicholas
See remarks
$413K 2026-03-02
Ranganath Anil P.
See remarks
$120K 2026-03-02
Hernandez Gerardo
Chief Financial Officer
$1.1M 2026-03-04
Cecere Giovanni
Chief Commercial Officer
2026-02-18